Related Experiment Video
Updated: Mar 22, 2026

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
[120 mmHg for everyone?]
1Nederlands Huisartsen Genootschap, afd.Richtlijnontwikkeling en Wetenschap, Utrecht.
Insights
Intensive blood pressure treatment to 120 mmHg significantly reduced heart attack, stroke, and death in high-risk patients. Shared decision-making is crucial for personalized antihypertensive therapy targets.
Area of Science:
- Cardiology
- Clinical Trials
- Hypertension Management
Background:
- The Systolic Blood Pressure Intervention Trial (SPRINT) investigated intensive blood pressure lowering targets.
- Elevated cardiovascular risk necessitates effective antihypertensive strategies.
Purpose of the Study:
- To evaluate the efficacy and safety of intensive systolic blood pressure (SBP) lowering to 120 mmHg compared to standard treatment (140 mmHg).
Main Methods:
- Randomized controlled trial involving 9161 patients with SBP 130-180 mmHg and increased cardiovascular risk.
- Comparison of intensive treatment (target 120 mmHg) versus standard treatment (target 140 mmHg).
Main Results:
- The trial was terminated early due to significant benefits in the intensive treatment group.
- Intensive treatment showed a lower incidence of myocardial infarction, stroke, heart failure, and cardiovascular death (HR 0.75; p < 0.001).
Conclusions:
- Lowering SBP to 120 mmHg is associated with reduced cardiovascular events in high-risk individuals.
- Future guidelines should emphasize shared decision-making for personalized blood pressure targets, balancing benefits and risks.
Abstract:
The recently published Systolic Blood Pressure Intervention Trial (SPRINT) casts new light on the issue of lowering blood pressure to 120 mmHg. The trial randomized 9161 patients with systolic blood pressures of 130 mmHg - 180 mmHg and increased cardiovascular risk into a group receiving intensive treatment (target 120 mmHg) and a group given standard treatment (target 140 mmHg). The trial was stopped earlier than foreseen because interim analysis showed a lower incidence rate of myocardial infarction, stroke, heart failure and death from cardiovascular causes in the group given intensive treatment (1.65 versus 2.19 per year, hazard ratio 0.75; 95% CI 0.64-0.89; p < 0.001). These results open up the possibility of aiming for lower blood pressure targets in antihypertensive treatment. It is questionable whether this strategy would be preferred by every patient. New guidelines on cardiovascular risk management should pay more attention to shared decision-making where doctors inform patients about the benefits and risks of strict or less strict blood pressure control and patients choose personal targets.
Related Concept Videos
Blood Pressure
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
Hypertension I: Introduction
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Sites for measuring blood pressure
The Brachial Artery: Primary Site for Blood Pressure Measurement
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.

